Treatment strategies in mild asthma

Area of Science:

• Pulmonology
• Allergy and Immunology
• Pharmacology

Background:

• Mild asthma classification was divided into mild intermittent and mild persistent categories over a decade ago.
• Low-dose inhaled corticosteroids (ICS) were recommended for mild persistent asthma, with an arbitrary threshold for initiation.
• Lack of specific clinical studies led to an arbitrary decision on initiating regular ICS therapy.

Purpose of the Study:

• To review the evidence for current treatment guidelines for mild asthma.
• To explore alternative therapeutic strategies for mild persistent asthma.
• To evaluate new treatment options beyond regular low-dose ICS.

Main Methods:

• Review of recent clinical trials and scientific literature.
• Analysis of treatment outcomes for mild persistent asthma.
• Evaluation of alternative therapeutic approaches.

Main Results:

• Recent trials question the universal recommendation of regular ICS for all mild asthma patients.
• The optimal treatment outcomes for mild persistent asthma are under discussion.
• New strategies are being investigated for efficacy and tolerability in mild persistent asthma.

Conclusions:

• Combination therapy (ICS/long-acting b2-agonists) and oral leukotriene antagonists show promise.
• Intermittent or as-needed ICS use is an alternative to regular treatment.
• Limited research exists on alternatives to as-needed bronchodilation for mild intermittent asthma.